Key result
Eliminating stable AF sources links to ~62-point higher freedom from AF vs. missing them.
Why the study?
It was unclear why conventional anatomical AF ablation is effective in some patients yet ineffective in others with similar profiles. This study examined whether direct or coincidental ablation of stable AF rotors or focal sources explains long-term freedom from AF.
Does direct or coincidental catheter ablation of stable AF rotors and focal sources improve long-term freedom from atrial fibrillation compared to ablation that misses all sources?
Cohort (n=94)
Blinded outcome/map assessment (Electroanatomic and FIRM maps were analyzed per patient blinded to demographics, outcomes or assignment)
Non-randomized, assigned 2:1 to FIRM-blinded (conventional) ablation alone or FIRM-guided ablation
Does direct or coincidental catheter ablation of stable AF rotors and focal sources improve long-term freedom from atrial fibrillation compared to ablation that misses all sources?
Absolute Event Rate: 80.3% vs 18.2%
p-value: p=<0.001
This on-treatment analysis of the CONFIRM trial demonstrates that eliminating patient-specific stable AF rotors or focal sources—whether directly via FIRM mapping or coincidentally via anatomical lesion sets—strongly predicts single-procedure freedom from AF.
Objective: We hypothesized that ablation of recently described stable AF sources, either directly by Focal Impulse and Rotor Modulation (FIRM) or coincidentally when anatomical ablation passes through AF sources, may explain long term freedom of AF. Background: It is unclear why conventional anatomical AF ablation can be very effective in some patients yet ineffective in others with similar profiles. Methods: The CONFIRM trial prospectively revealed stable AF rotors or focal sources in 98/101 subjects with AF at 107 consecutive ablation cases. In 1:2 fashion, subjects received targeted source ablation (FIRM) then conventional ablation, or conventional ablation alone. We determined if ablation lesions on electroanatomic maps passed through AF sources on FIRM maps. Results: Subjects who completed followup (n=94, 71.2% persistent AF) each showed 2.3±1.1 concurrent AF rotors or focal sources, that lay near pulmonary veins (22.8%), left atrial roof (16.0%), and elsewhere in left (28.2%) and right (33.0%) atria. AF sources were ablated directly in 100% FIRM cases and coincidentally (e.g. left atrial roof) in 45% conventional cases (p<0.05). During 273 days (median, IQR 138–636) after 1 procedure, AF was absent in 80.3% of patients if sources were ablated but recurred in 81.8% of patients if sources were missed (p<0.001). Freedom from AF was highest if all sources were ablated, intermediate if some sources were ablated, and lowest if no sources were ablated (p<0.001). CONCLUSIONS: Elimination of stable AF rotors and focal sources may explain freedom from AF after diverse approaches to ablation. Patient-specific AF source distributions are consistent with the reported success of specific anatomical lesion sets, and of widespread ablation. These results support targeting AF sources to reduce unnecessary ablation, and motivate studies on FIRM-only ablation.
No takes yet. Share an insight, caveat, or question.
Narayan et al. (2013) conducted a cohort in Atrial fibrillation (paroxysmal, persistent, and longstanding persistent) (n=94). Direct (FIRM-guided) or coincidental (conventional anatomical) ablation passing through stable AF rotors or focal sources vs. Ablation missing all stable AF sources (no-source ablation) was evaluated on Freedom from AF after a single procedure (<1% burden on continuous implanted ECG monitors or AF <30 seconds on intermittent monitors) (p=<0.001). Direct or coincidental ablation of stable AF sources achieved 80.3% freedom from AF compared to 18.2% when sources were missed (p<0.001) at a median 273 days.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: